For research use only. Not for therapeutic Use.
HIF-1 inhibitor-4 is a HIF-1 inhibitor (IC50: 560 nM). HIF-1 inhibitor-4 reduces the HIF-1α protein level without affecting its mRNA level[1].
HIF-1 inhibitor-4 (Compound 1) inhibits HIF-1 with an IC50 of 560 nM, quantified using U251 cell expressing a PLAP reporter gene under the control of a VEGF promoter (VEGF-PLAP)[1].
Catalog Number | I041720 |
CAS Number | 333357-56-5 |
Synonyms | N-(4-iodophenyl)-4-(morpholin-4-ylmethyl)benzamide |
Molecular Formula | C18H19IN2O2 |
Purity | ≥95% |
InChI | InChI=1S/C18H19IN2O2/c19-16-5-7-17(8-6-16)20-18(22)15-3-1-14(2-4-15)13-21-9-11-23-12-10-21/h1-8H,9-13H2,(H,20,22) |
InChIKey | ZOFBYPLMJZJZIK-UHFFFAOYSA-N |
SMILES | C1COCCN1CC2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)I |
Reference | [1]. Nagao S, et al. Synthesis and structure-activity relationships of novel, potent, orally active hypoxia-inducible factor-1 inhibitors. Bioorg Med Chem. 2014 Oct 1;22(19):5513-29. |